Orthopedic Surgical Oncology Clinic
The UCSF Orthopedic Surgical Oncology Clinic provides expert care for benign and malignant bone and soft tissue tumors, as well as conditions similar to tumors. To deliver individualized care of the highest quality, we coordinate treatment by a team of surgeons, radiologists, pathologists, medical and radiation oncologists, and other health professionals at the UCSF Helen Diller Family Comprehensive Cancer Center.
Our locations
U.S. News rankings
-
Among the top hospitals in the nation
-
Best in Northern California for cancer care (tie)
-
One of the nation's best for orthopedic care
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a founding member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Original film and radiology slides (please hand carry to appointment)
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- List of questions you may have
- Device or paper for taking notes
Related clinics
Our research initiatives
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.
